lead position
Sponsored content
Sponsored by
GlobalBlock
Features list
-
Maria Nebreda of Hoet Peláez Castillo & Duque analyses the scope of a draft law in Venezuela that aims to validate and protect the work of artists and deepen the country’s cultural heritage
-
Phillip Bausk explains the US patent reforms under the America Invents Act and how the life sciences industry is adapting to them
-
The subject of gene patentability is one of the most controversial topics in life sciences. In June 2013, the US Supreme Court reached a unanimous decision in the Association for Molecular Pathology v Myriad Genetics. It stated that companies cannot patent parts of naturally occurring human genes. Managing IP sat down with Fitzpatrick Cella Harper & Scinto attorneys Robert Fischer, John Carlin and Joshua Rothman to discuss the ruling
-
The head of patent litigation outside the US, Jurgen Dressel has always stood out for his willingness to discuss the issues driving his industry. He tells James Nurton why litigation will increase and the “whittling away” of rights in many countries
-
Dechert attorneys Christine C Levin and Irene Ayzenberg-Lyman provide an overview of the recent US Supreme Court decision, FTC v Actavis
-
Archana Shanker and Devinder Singh Rawat of Anand & Anand discuss the rise and regulation of biosimilar biologics in the Indian pharmaceutical market
Local Insights